Treatment with lipoprotein apheresis is associated with significant decrease of biomarkers related to endothelial dysfunction and inflammation not only after each procedure but in the long-term follow-up of up to 15 years, in both HeFH and HoFH patients
Autor: | Blaha, V., Blaha, M., Lánská, M., Andrýs, C., Tebbens, J.D., Sá, I. C. Igreja, Tripská, K., Vicen, M., Víšek, J., Lášticová, M., Nachtigal, P. |
---|---|
Zdroj: | In Atherosclerosis August 2021 331:e135-e136 |
Databáze: | ScienceDirect |
Externí odkaz: |